ConductScience.org, home

Paper1757079

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Elston CW and 1 other. Histopathology, 1991. Cited by 4,895 papers, by iCite.

Cite this record

ConductScience Library. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Papers, record 1757079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1757079

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
PubMed
Journal
Histopathology
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4,895
iCite
Relative citation ratio, by iCite
133
iCite
Revised in PubMed
2025-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elston CWC W
2Ellis IOI O

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Follow-Up Studies
Histological Techniques
Humans
Mitotic Index
Neoplasm Recurrence, Local
Prognosis

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03917082Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Reprinted in12405947Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.https://conductscience.org/library/papers/12405947PubMed
Comment in12405945
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410.
https://conductscience.org/library/papers/12405945PubMed

Download CSV of comments and corrections

Cited by1,987

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,895 citations.

PMIDTitleJournalYearIn PapersSource
42972452
Multicenter development and validation of a serum microRNA-based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study.
Breast Cancer Res2026https://conductscience.org/library/papers/42972452PubMed
42964509Label- and Slide-Free Multispectral Quantitative Epi-Illumination Deep-Ultraviolet Microscopy.BME Front2026https://conductscience.org/library/papers/42964509PubMed
42954225Molecular Subtypes and Treatment Modalities in Breast Cancer in a Brazilian Military Hospital: An Observational Study.Biomed Res Int2026https://conductscience.org/library/papers/42954225PubMed
42929994Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study.Diseases2026https://conductscience.org/library/papers/42929994PubMed
42923317Immunohistochemical Expression of Proliferating Cell Nuclear Antigen in Invasive Breast Carcinoma: Associations With Histological Grade and Ki-67 Expression.Cureus2026https://conductscience.org/library/papers/42923317PubMed
42897655Do new guidelines enable a more accurate comparison of [18F]FDG PET/CT features with histopathology in primary breast cancer?Breast Cancer Res2026https://conductscience.org/library/papers/42897655PubMed
42883719Lipid Composition in the Breast of Premenopausal BRCA1/2 Genetic Mutation Carriers Using MRI.Int J Mol Sci2026https://conductscience.org/library/papers/42883719PubMed
42882846Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study.Cancers (Basel)2026https://conductscience.org/library/papers/42882846PubMed
42882793Transfer Learning-Based Quantification of Mitotic Activity and Its Prognostic and Molecular Associations in Lung Squamous Cell Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42882793PubMed
42855725Accurate assessment of surgical HER2-low status based on core needle biopsy data of breast cancer.Diagn Progn Res2026https://conductscience.org/library/papers/42855725PubMed
42844328ESR1 mutations are associated with enhanced MTORC1 signaling in a context-dependent manner.Commun Biol2026https://conductscience.org/library/papers/42844328PubMed
42793819
Concordance of Digital Breast Tomosynthesis (DBT) and Magnetic Resonance Imaging (MRI) Measured Tumor Size with the Pathological Gold Standard: A Retrospective Cohort Analysis by Molecular Subtype and Breast Density.
Diagnostics (Basel)2026https://conductscience.org/library/papers/42793819PubMed
42787006Contralateral Primary Small-Cell Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation in a Patient With Prior Invasive Ductal Carcinoma: A Rare Case.Cureus2026https://conductscience.org/library/papers/42787006PubMed
42763585Histomorphological and Immunohistochemical Profile of Malignant Breast Lesions in a Tertiary Care Center of Central India: A Cross-Sectional Study.Cureus2026https://conductscience.org/library/papers/42763585PubMed
42718887The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42718887PubMed
42717518Serum Levels of Thyroid Hormones in Relation to Breast Cancer Prognosis: A Multicentre Cohort Study.Cancer Med2026https://conductscience.org/library/papers/42717518PubMed
42701629Prognostic value of ultrasound Breast Imaging Reporting and Data System for disease-free survival in early-stage breast cancer: a retrospective study (2011-2018).Quant Imaging Med Surg2026https://conductscience.org/library/papers/42701629PubMed
42699720
Immunohistochemical Expression of Programmed Death-Ligand 1 (PD-L1) in Breast Carcinoma and Its Correlation With Estrogen Receptor, Progesterone Receptor and HER2/neu Status: A Single-Centre Study From Central India.
Cureus2026https://conductscience.org/library/papers/42699720PubMed
426873441H HR-MAS NMR Metabolomics in Combination With Transcriptomic Correlation Provides New Insights Into Metabolic Heterogeneity Across Breast Cancer Immunohistochemical Subtypes.NMR Biomed2026https://conductscience.org/library/papers/42687344PubMed
42680767A human epithelial cell cycle dataset.Sci Data2026https://conductscience.org/library/papers/42680767PubMed

See all 1,987 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1757079

GET https://conductscience.org/api/papers/v1/1757079/cited_by?page=2